Penn Radiology – Oncologic Imaging Essentials 2020
Penn Radiology responds to the constant challenge of Cancer imaging with Oncologic Imaging Essentials. This activity includes a review of the diagnostic imaging evaluation of common tumors, including breast, head and neck, thoracic and abdominal malignancies. Current state of the art modalities used for oncologic imaging, including CT, MRI, ultrasound, PET-CT and digital mammography will be discussed. Emphasis is placed on the role of imaging in staging, treatment and follow up in order to optimize care of oncologic patients.
Topics: Thyroid cancer, orbital neoplasia, head and neck cancer, GI and GU tumors, abdominal incidentalomas, prostate cancer, tomosynthesis, breast screening, high risk lesions, GYN malignancies, CT colonography, FDG PET-CT and much more!
Session 1: Head and Neck
| Viral-Induced Neoplasia of the Head and Neck | Laurie A. Loevner, MD |
| Laryngeal Cancer: What the Clinician Needs to Know | Laurie A. Loevner, MD |
| PET/CT in Head and Neck Cancer: Pearls and Pitfalls | Laurie A. Loevner, MD |
| TI-RADS and Thyroid Cancer Detection | Jill Langer, MD |
| Orbital Neoplasia Patterns of Spread | Laurie A. Loevner, MD |
| Robotics in Head and Neck Cancer: Emphasis on Oropharyngeal Cancer | Laurie A. Loevner, MD |
Session 2: Body Imaging I: Abdomen and Prostate
| Imaging of Upper GI Tract Tumors | Susan L. Summerton, MD |
| Imaging of GU Tract Malignancies | Susan L. Summerton, MD |
| Incidentalomas on Abdominal Imaging | Susan L. Summerton, MD |
| Prostate Cancer Update | Jill Langer, MD |
Session 3: Breast
| Digital Breast Tomosynthesis: Today and Tomorrow | Samantha P. Zuckerman, MD |
| Update on Screening MR – Not Just for BRCA Patients | Samantha P. Zuckerman, MD |
| Management of High Risk Breast Lesions | Samantha P. Zuckerman, MD |
| Imaging Special Populations | Samantha P. Zuckerman, MD |
| Challenging Cases in Breast Imaging | Samantha P. Zuckerman, MD |
Session 4: Body Imaging II: GYN and Colonography
| Non-Ovarian GYN Malignancy- What Role Does the Radiologist Play? | Jill Langer, MD |
| Ovarian Cancer Screening | Jill Langer, MD |
| Screening for Colon Cancer: Role of CT Colonograpy | Susan L. Summerton, MD |
| Pre- and Post-Operative Imaging of the Colon | Susan L. Summerton, MD |
Session 5: Nuclear Medicine Indications and Applications
| Accepted Indications for FDG PET/CT | Daniel A. Pryma, MD |
| Pearls and Pitfalls in FDG PET/CT | Daniel A. Pryma, MD |
| FDG PET/CT in Response Assessment: Solid Tumors, Lymphoma, and Immunotherapy | Daniel A. Pryma, MD |
| Beyond FDG: PET/CT with Ga-68 DOTATATE, F-18 Fluciclovine, and PSMA | Daniel A. Pryma, MD |
| The Role of Nuclear Medicine in Thyroid Disease | Daniel A. Pryma, MD |
| Challenging Nuclear Medicine Cases | Daniel A. Pryma, MD |
Release Date: 4/15/20
CME Expiration: 4/14/23
